Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05179486 | RECRUITING | Cholangiocarcinoma

Molecular Epidemiology of Biliary Tree Cancers
Sponsor:

M.D. Anderson Cancer Center

Brief Summary:

This study is to learn if certain risk factors (environmental, viral, behavioral, medical, and dietary), tumor markers, and genetic changes can predict the development and outcome of biliary tree cancers. Establishing biomarkers models from patients may help doctors to further understand how biliary tree cancer is affected by different treatments, and why some people's cancer responds differently than others.

Condition or disease

Cholangiocarcinoma

Malignant Digestive System Neoplasm

Intervention/treatment

Biospecimen Collection

Questionnaire Administration

Detailed Description:

PRIMARY OBJECTIVES: I. To identify significant factors that may contribute to the etiology of biliary tree cancer. II. To identify novel genetic loci that predispose to gallbladder cancers (GBC) and cholangiocarcinoma (CGC) diagnosis. EXPLORATORY AND CORRELATIVE OBJECTIVES: I. To use the collected blood and tissue materials for exploratory analysis to identify markers that predict prognosis of biliary tree cancers. II. To correlate the identified markers with results of specific aim I and II to test the interaction between the identified markers with environmental and genetic factors. OUTLINE: Participants complete a questionnaire over 20 minutes. Participants also undergo collection of blood and leftover tissue samples.

Study Type : OBSERVATIONAL
Estimated Enrollment : 1500 participants
Official Title : Molecular Epidemiology of Biliary Tree Cancers
Actual Study Start Date : 2017-09-25
Estimated Primary Completion Date : 2027-02-02
Estimated Study Completion Date : 2027-02-02

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Criteria
Inclusion Criteria
  • * Pathologically or radiologically confirmed diagnosis of CGC or GBC
  • * With or without prior radiation or chemotherapy
  • * All United States of America (USA) and non USA residents
  • * No age, gender, or racial restriction
  • * Healthy control with no current or history of cancer
  • * Healthy controls are USA and non USA residents
  • * Healthy controls are matched to the cases in age (5 years), gender, and race
  • * Healthy controls are friends and spouses of patients with other than gastro-intestinal (GI) cancers
  • * Chronic Liver Disease (CLD) controls with no current or history of cancer
  • * CLD controls are USA and non USA residents
  • * CLD controls are frequency matched to CGC cases by age (5 years), gender, and race
  • * CLD controls are patients are diagnosed with or without liver biopsy (core or fine needle aspiration)
  • * CLD controls must not have evidence liver cancer diagnosis by computed tomography (CT) or magnetic resonance imaging (MRI)
Exclusion Criteria
  • * None
Molecular Epidemiology of Biliary Tree Cancers

Location Details

NCT05179486

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Texas

M D Anderson Cancer Center

Houston, Texas, United States, 77030